SJ Medical
The global medical landscape is witnessing a significant shift in the management of Peripheral Artery Disease (PAD), specifically concerning Below-the-Knee (BTK) interventions. As the world faces an aging population and rising rates of diabetes and chronic kidney disease, the prevalence of Critical Limb Ischemia (CLI) has reached an all-time high. BTK intervention is no longer just a specialized procedure; it is a vital frontier in Limb Salvage, aiming to prevent major amputations and improve the quality of life for millions.
In developed regions such as North America and Europe, the demand for sophisticated BTK devices like Drug-Coated Balloons (DCB) and Micro-guidewires is driven by a shift toward outpatient endovascular centers. Meanwhile, in emerging markets across Asia and the Middle East, there is an urgent need for BTK Intervention Factories that can provide high-quality, cost-effective interventional tools. As a premier supplier, SJ Medical stands at the intersection of innovation and accessibility, ensuring that healthcare providers globally have access to the latest vascular interventional technologies.
The global peripheral intervention market is projected to grow at a CAGR of 7.5%, with BTK procedures being the fastest-growing segment due to diabetic foot complications.
Industry trends are moving from traditional balloon angioplasty to advanced bioresorbable scaffolds and precision atherectomy devices for infrapopliteal arteries.
Hospitals are increasingly seeking "One-Stop" interventional solutions that combine diagnostic catheters, access systems, and therapeutic devices.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment.
Our facility includes a million-class clean workshop with localized hundred-class areas for critical processes, ensuring the highest sterility and safety for interventional devices.
Led by senior engineers with decades of experience in the medical device industry, maintaining strict quality control and continuous improvement in manufacturing processes.
For global distributors and hospital procurement managers, selecting a BTK Intervention Supplier involves rigorous evaluation of clinical efficacy, regulatory compliance, and supply chain stability. As a leading Chinese factory, SJ Medical addresses these needs by combining high-end R&D with large-scale production efficiency.
As a specialized BTK Intervention Factory, we provide a localized application perspective. In Southeast Asia, for example, where diabetes-related CLI is rampant, our cost-effective balloon catheters allow hospitals to perform more limb-saving procedures within limited budgets. In Europe, our adherence to ISO 13485 and CE standards ensures that our products meet the strictest safety requirements for premium clinical settings.
China has become a global hub for medical device manufacturing. Our advantage lies in a robust supply chain, rapid prototyping capabilities, and a significant cost-to-performance ratio compared to Western counterparts.
By controlling the entire process from balloon forming to laser welding, we guarantee product consistency—a critical factor in delicate BTK procedures where device failure is not an option.
We offer flexible manufacturing services for global partners looking to develop custom interventional tools tailored to specific anatomical challenges found in their local patient populations.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices.
Our products play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
We strictly adhere to international quality standards. SJ Medical has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval.
The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We continue to expand our international footprint and strengthen our global presence.
As a visionary BTK Intervention Supplier, we are looking toward the future of vascular medicine. The integration of Artificial Intelligence (AI) in procedural planning and the development of next-generation biomaterials are set to revolutionize how we treat arterial blockages below the knee. SJ Medical is committed to staying at the forefront of these trends by investing in R&D that focuses on improving "vessel patency" and reducing "target lesion revascularization" (TLR).
Our role as a BTK Intervention Factory involves more than just production; it involves collaboration with global clinicians to solve real-world problems. Whether it's developing ultra-tapered balloons for the smallest pedal arteries or creating safety systems that protect the vessel wall during complex interventions, our goal is to achieve optimal procedural outcomes for every patient.
Square Meters Factory Space
Global Export Countries
Certified Quality Standards
SJ Medical is committed to providing comprehensive and professional services throughout the entire customer journey. From pre-sales consultation and technical support to efficient order processing and responsive after-sales service, the company ensures that every customer receives timely assistance and reliable solutions.